These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31003940)

  • 1. Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection.
    Saleh MM; Frisbee AL; Leslie JL; Buonomo EL; Cowardin CA; Ma JZ; Simpson ME; Scully KW; Abhyankar MM; Petri WA
    Cell Host Microbe; 2019 May; 25(5):756-765.e5. PubMed ID: 31003940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice.
    Wang S; Deng W; Li F; Xiang L; Lv P; Chen Y
    J Nutr Biochem; 2023 Jan; 111():109155. PubMed ID: 36162566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27/IL-27 Receptor Signaling Provides Protection in Clostridium difficile-Induced Colitis.
    Wang L; Cao J; Li C; Zhang L
    J Infect Dis; 2018 Jan; 217(2):198-207. PubMed ID: 29140433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity.
    Yu H; Chen K; Sun Y; Carter M; Garey KW; Savidge TC; Devaraj S; Tessier ME; von Rosenvinge EC; Kelly CP; Pasetti MF; Feng H
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28592627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice with Inflammatory Bowel Disease are Susceptible to Clostridium difficile Infection With Severe Disease Outcomes.
    Zhou F; Hamza T; Fleur AS; Zhang Y; Yu H; Chen K; Heath JE; Chen Y; Huang H; Feng H
    Inflamm Bowel Dis; 2018 Feb; 24(3):573-582. PubMed ID: 29462386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing?
    Saleh MM; Petri WA
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31570564
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
    Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
    mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
    [No Abstract]   [Full Text] [Related]  

  • 8. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
    Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
    Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of T helper 17 cell function ameliorates recurrent Clostridioides difficile infection in mice.
    Wang S; Deng W; Li F; Chen YE; Wang PU
    Acta Biochim Biophys Sin (Shanghai); 2021 Oct; 53(10):1290-1299. PubMed ID: 34379099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute infection with Strongyloides venezuelensis increases intestine production IL-10, reduces Th1/Th2/Th17 induction in colon and attenuates Dextran Sulfate Sodium-induced colitis in BALB/c mice.
    Rodrigues VF; Bahia MPS; Cândido NR; Moreira JMP; Oliveira VG; Araújo ES; Rodrigues Oliveira JL; Rezende MC; Correa A; Negrão-Corrêa D
    Cytokine; 2018 Nov; 111():72-83. PubMed ID: 30118915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
    Solanky D; Pardi DS; Loftus EV; Khanna S
    Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 23 signaling in Clostridium difficile colitis.
    Buonomo EL; Madan R; Pramoonjago P; Li L; Okusa MD; Petri WA
    J Infect Dis; 2013 Sep; 208(6):917-20. PubMed ID: 23776194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
    Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
    Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
    Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.
    Sokol H; Lalande V; Landman C; Bourrier A; Nion-Larmurier I; Rajca S; Kirchgesner J; Seksik P; Cosnes J; Barbut F; Beaugerie L
    Dig Liver Dis; 2017 Jun; 49(6):643-646. PubMed ID: 28215602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated Receptor 1 Plays a Proinflammatory Role in Colitis by Promoting Th17-related Immunity.
    Saeed MA; Ng GZ; Däbritz J; Wagner J; Judd L; Han JX; Dhar P; Kirkwood CD; Sutton P
    Inflamm Bowel Dis; 2017 Apr; 23(4):593-602. PubMed ID: 28296821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.